Clinical Trials Logo

Hemorrhagic Complications clinical trials

View clinical trials related to Hemorrhagic Complications.

Filter by:
  • None
  • Page 1

NCT ID: NCT05292326 Recruiting - Hemorrhage Clinical Trials

Safety and Efficiency of the PacePress to Prevent Hemorrhagic Complications in Patients Undergoing CIED Implantation.

PacePress
Start date: May 25, 2021
Phase: N/A
Study type: Interventional

PacePress medical device, by ensuring constant compression force and the ability to optimize it in the pocket area prevents/significantly reduces the risk of hemorrhagic complications, including but not limited to the operation pocket hematoma. By avoiding a strong localized compression and ensuring "covering compression" achieved by the appropriate distribution of compression forces on the entire implantation site area, with an automated compression force control, the risk of a pressure sore created in the compressed pocket area is reduced.

NCT ID: NCT01045850 Completed - Clinical trials for Cardiovascular Complications

Prospective Cohort of Patient With Coronary Stents Undergoing Non Cardiac Surgery

RECO
Start date: February 2006
Phase: N/A
Study type: Observational

Non cardiac surgery in patients with coronary stents is complicated with cardiovascular and hemorrhagic events associated with perioperative management of antiplatelet agents. Several guidelines have outlined the importance of maintaining antiplatelet agents throughout surgical procedures to prevent cardiovascular complications. On the other hand, interruption of antiplatelet agents is still a usual standard to avoid surgical complications. We investigate the impact of perioperative antiplatelet drugs management on these complications, through a multicenter, prospective cohort (RECO stands for "Registre des patients porteurs d'Endoprothèses Coronaires, Opérés de chirurgie non cardiaque"), including all patients with coronary stents undergoing non cardiac surgery or invasive procedures. The aim of this study is primarily to measure the incidence of cardiovascular (including stent thrombosis) and hemorrhagic complications and to identify pre and postoperative risk factors associated with these complications.